| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | ANKRD13B CTTNBP2 ANK1 ANK3 LRRK2 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 2.61e-06 | 248 | 168 | 12 | 1.25.40.20 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD13B CTTNBP2 ANK1 ANK3 LRRK2 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 3.34e-06 | 254 | 168 | 12 | IPR020683 |
| Domain | Ank_2 | ANKRD13B CTTNBP2 ANK1 ANK3 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 4.05e-06 | 215 | 168 | 11 | PF12796 |
| Domain | Ankyrin_rpt | ANKRD13B CTTNBP2 ANK1 ANK3 LRRK2 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 4.60e-06 | 262 | 168 | 12 | IPR002110 |
| Domain | Ank | ANKRD13B CTTNBP2 ANK1 ANK3 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 7.10e-06 | 228 | 168 | 11 | PF00023 |
| Domain | ANK | ANKRD13B CTTNBP2 ANK1 ANK3 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 1.75e-05 | 251 | 168 | 11 | SM00248 |
| Domain | ANK_REPEAT | ANKRD13B CTTNBP2 ANK1 ANK3 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 1.88e-05 | 253 | 168 | 11 | PS50088 |
| Domain | ANK_REP_REGION | ANKRD13B CTTNBP2 ANK1 ANK3 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 1.95e-05 | 254 | 168 | 11 | PS50297 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 MROH9 EDC3 SETX ANK1 NACC1 HSPH1 OBSCN NARS1 RNF213 ANKRD20A3P REV3L CTTNBP2NL ESCO1 NUP205 JUP SAMD9L DST PLXNA4 UTP20 PRKDC DYNC1H1 ELP4 | 4.01e-12 | 736 | 176 | 23 | 29676528 |
| Pubmed | SMCHD1 U2SURP POLRMT NARS1 ZNF318 EDC4 LARP4 TASOR2 NUP205 DST NF1 PRRC2C NUP133 ZNF638 KIF14 UTP20 PRKDC HERC2 GCN1 TOP1 DYNC1H1 | 2.17e-11 | 653 | 176 | 21 | 22586326 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PMS1 EDC3 ATRX NACC1 SMCHD1 U2SURP HSPH1 NACA ZNF318 EDC4 MDH2 AHSA1 JUP UBA1 DST ALMS1 PRRC2C TPX2 NUP133 ZNF638 PRKDC GCN1 TOP1 RBM17 | 7.56e-11 | 934 | 176 | 24 | 33916271 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | EDC3 RPGRIP1L U2SURP PBK ARHGEF18 ZNF318 STIL ALMS1 LRP1 KIF14 CEP152 ANKRD12 | 1.98e-10 | 184 | 176 | 12 | 32908313 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NIBAN1 SMCHD1 U2SURP NACA ZNF318 EDC4 MDH2 SMC2 NUP205 JUP UBA1 DST NF1 NUP133 ZNF638 KIF14 UTP20 PRKDC GNAS HERC2 GCN1 TOP1 DYNC1H1 RBM17 | 4.80e-10 | 1024 | 176 | 24 | 24711643 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SETX ATRX RBM45 SMCHD1 U2SURP EDC4 SMC2 EXOC5 NF1 TPX2 ZNF638 PRKDC GNAS CDC27 GCN1 TOP1 DYNC1H1 RBM17 | 1.18e-09 | 582 | 176 | 18 | 20467437 |
| Pubmed | KCNH7 RPGRIP1L SMCHD1 U2SURP LRRK2 PIWIL4 APOB CTTNBP2NL ZNF462 DST SH3PXD2A ASXL3 PRKDC HERC2 TOP1 ALPK2 RBM17 | 1.25e-09 | 513 | 176 | 17 | 25798074 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | U2SURP HSPH1 NACA POLRMT MDH2 SMC2 UBA1 PRKDC CDC6 GCN1 TOP1 DYNC1H1 | 1.62e-09 | 221 | 176 | 12 | 29991511 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | PMS1 BRIP1 EDC3 ATRX SMCHD1 HSPH1 NACA ZNF318 JUP UBA1 PLPBP PRKDC GCN1 DYNC1H1 | 4.62e-09 | 357 | 176 | 14 | 37059091 |
| Pubmed | RAP1GAP CTTNBP2 THSD7A GNPTAB HSPH1 ARHGEF18 RNF213 ESCO1 ZNF462 ASAP2 SAMD9L NPHP3 ALMS1 ZNF616 CEP152 DOP1A | 5.25e-09 | 493 | 176 | 16 | 15368895 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATRX SMCHD1 U2SURP HSPH1 NACA POLRMT APOB EDC4 MDH2 SMC2 AHSA1 NUP205 JUP UBA1 NF1 PRKAA2 NUP133 KIF14 UTP20 PLPBP PRKDC TAF5L GNAS GCN1 TOP1 DYNC1H1 | 1.57e-08 | 1425 | 176 | 26 | 30948266 |
| Pubmed | SETX RPGRIP1L ATRX NACC1 SMCHD1 SMC2 TASOR2 NUP205 ZNF462 ALMS1 PRRC2C TPX2 NUP133 ZNF638 GCN1 | 1.95e-08 | 469 | 176 | 15 | 27634302 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SAMD9 SMCHD1 HSPH1 NACA POLRMT NARS1 EDC4 SMC2 AHSA1 TASOR2 NUP205 JUP UBA1 DST PRRC2C TPX2 NUP133 ZNF638 KIF14 UTP20 PRKDC GNAS TOP1 DYNC1H1 | 2.54e-08 | 1257 | 176 | 24 | 36526897 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SEMA4D ANK3 ATRX GAS6 ASH1L OBSCN ARHGEF18 RNF213 LARP4 LRRC8D ESCO1 TASOR2 TATDN3 ZNF462 RANBP17 ASAP2 SH3PXD2A PVR TBCK PRKAA2 LRP1 ZNF638 ANKRD12 GNAS MTARC1 DOP1A | 3.77e-08 | 1489 | 176 | 26 | 28611215 |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 4.37e-08 | 8 | 176 | 4 | 12634303 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX SMCHD1 U2SURP HSPH1 NACA POLRMT NARS1 SMC2 LARP4 NUP205 JUP UBA1 DST NF1 NUP133 ZNF638 UTP20 PRKDC HERC2 CDC27 RIOK2 GCN1 TOP1 DYNC1H1 | 9.98e-08 | 1353 | 176 | 24 | 29467282 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | EDC3 U2SURP NACA EDC4 CTTNBP2NL ESCO1 TASOR2 ITPR1 UBA1 TPX2 NUP133 TSEN34 KIF14 CEP152 PRKDC GNAS HERC2 CDC6 CDC27 GCN1 DYNC1H1 RBM17 | 1.07e-07 | 1155 | 176 | 22 | 20360068 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ATRX SMCHD1 NARS1 RNF213 EDC4 SMC2 UBA1 TPX2 ZNF638 PRKDC GCN1 DYNC1H1 | 1.46e-07 | 332 | 176 | 12 | 32786267 |
| Pubmed | ANK3 SMCHD1 ZNF318 EDC4 SMC2 JUP UBA1 ALMS1 PRRC2C TPX2 KIF14 PRKDC GCN1 DYNC1H1 ELP4 | 1.51e-07 | 549 | 176 | 15 | 38280479 | |
| Pubmed | BRIP1 EDC3 RPGRIP1L ICE2 NACA ARHGEF18 RNF213 DGKE LARP4 ALMS1 TTLL4 ARNT2 TPX2 ZNF638 KIF14 PLPBP ELP4 | 2.23e-07 | 733 | 176 | 17 | 34672954 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANK3 SMCHD1 SAMD9L NF1 PRRC2C ASXL3 KIF14 ZNF616 MTBP PRKDC CPLANE1 TOP1 | 3.57e-07 | 361 | 176 | 12 | 26167880 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SMCHD1 NACA POLRMT SMC2 LARP4 NUP205 EXOC5 PRRC2C TPX2 NUP133 UTP20 PRKDC HERC2 CDC6 GCN1 TOP1 RBM17 | 3.63e-07 | 759 | 176 | 17 | 35915203 |
| Pubmed | EDC3 SETX ANK3 ATRX HSPH1 ASH1L OBSCN CD55 ARHGEF18 APOB ZNF318 STAT6 ITPR1 JUP NPHP3 TTLL4 ZNF638 ANKRD12 CPLANE1 CDC27 | 6.93e-07 | 1084 | 176 | 20 | 11544199 | |
| Pubmed | EDC3 ANK3 ICE2 HSPH1 NARS1 SMC2 JUP UBA1 DST PRRC2C PRKDC CRYBG3 CDC27 GCN1 TOP1 DYNC1H1 | 7.24e-07 | 708 | 176 | 16 | 39231216 | |
| Pubmed | SETX SMCHD1 U2SURP HSPH1 POLRMT APOB MDH2 LARP4 ADAM10 JUP UBA1 DST PRRC2C PVR TPX2 PRKDC GNAS CDC27 RIOK2 TOP1 DYNC1H1 RBM17 | 7.54e-07 | 1297 | 176 | 22 | 33545068 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.14e-07 | 256 | 176 | 10 | 33397691 | |
| Pubmed | SMCHD1 U2SURP HSPH1 NACA POLRMT EDC4 MDH2 SMC2 LARP4 JUP UBA1 PRKDC CDC27 GCN1 TOP1 DYNC1H1 ALPK2 | 8.73e-07 | 809 | 176 | 17 | 32129710 | |
| Pubmed | SETX NACC1 SMCHD1 U2SURP HSPH1 CASP1 NARS1 ZNF318 AASDH EDC4 SMC2 AHSA1 UBA1 PRRC2C TPX2 PRKDC TAF5L TOP1 DYNC1H1 RBM17 | 9.06e-07 | 1103 | 176 | 20 | 34189442 | |
| Pubmed | SMCHD1 U2SURP HSPH1 NACA OBSCN NARS1 LEPR UBA1 PRKDC TOP1 DYNC1H1 | 1.22e-06 | 334 | 176 | 11 | 30425250 | |
| Pubmed | BRIP1 ATRX SMCHD1 NACA APOB MDH2 SMC2 ITPR1 NUP205 JUP TPX2 ZNF638 PRKDC GNAS TOP1 | 1.31e-06 | 652 | 176 | 15 | 31180492 | |
| Pubmed | SMCHD1 U2SURP EDC4 ITPR1 NUP205 NUP133 UTP20 CEP152 PRKDC TOP1 DYNC1H1 | 1.45e-06 | 340 | 176 | 11 | 29478914 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SETX APOB AASDH STIL BBS10 NF1 LRP1 MTBP LTK HERC2 ELP4 DOP1A | 1.74e-06 | 420 | 176 | 12 | 28065597 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAP1GAP EDC3 SETX STIL EDC4 JUP DST NF1 ALMS1 SH3PXD2A PRRC2C PRKAA2 KIF14 CEP152 CRYBG3 GNAS DOP1A | 2.03e-06 | 861 | 176 | 17 | 36931259 |
| Pubmed | NIBAN1 EDC3 KATNB1 RNF213 DGKE EDC4 LARP4 ADAM10 LRRC8D ITPR1 NUP205 NF1 PRRC2C NUP133 KIF14 PRKDC GNAS HERC2 GCN1 DYNC1H1 | 2.17e-06 | 1168 | 176 | 20 | 19946888 | |
| Pubmed | 2.41e-06 | 225 | 176 | 9 | 12168954 | ||
| Pubmed | 2.51e-06 | 76 | 176 | 6 | 27542412 | ||
| Pubmed | EDC3 CTTNBP2 NACC1 PBK CTTNBP2NL DST NF1 ALMS1 SH3PXD2A KIF14 CEP152 PRKDC | 3.23e-06 | 446 | 176 | 12 | 24255178 | |
| Pubmed | EDC3 ATRX NACC1 SMCHD1 HSPH1 NACA ZNF318 EDC4 LARP4 NUP205 ZNF462 JUP DST ALMS1 PRRC2C TPX2 ZNF638 CEP152 TAF5L HERC2 TOP1 DYNC1H1 | 3.65e-06 | 1429 | 176 | 22 | 35140242 | |
| Pubmed | HSPH1 NACA POLRMT NARS1 RNF213 DGKE EDC4 MDH2 SMC2 ADAM10 ITPR1 NUP205 EXOC5 DST PRRC2C NUP133 KIF14 PRKDC GNAS GCN1 DYNC1H1 RBM17 | 4.12e-06 | 1440 | 176 | 22 | 30833792 | |
| Pubmed | 4.36e-06 | 242 | 176 | 9 | 34011540 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 4.91e-06 | 313 | 176 | 10 | 38270169 | |
| Pubmed | U2SURP HSPH1 NACA MDH2 LARP4 TASOR2 JUP UBA1 PRRC2C PLPBP PRKDC TOP1 RBM17 | 5.21e-06 | 551 | 176 | 13 | 34728620 | |
| Pubmed | 5.54e-06 | 87 | 176 | 6 | 33711283 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 5.54e-06 | 87 | 176 | 6 | 17148452 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | EDC3 THSD7A ATRX SMCHD1 MDH2 ITPR1 NF1 PRRC2C SLIT1 PLCB1 HERC2 TOP1 | 6.12e-06 | 475 | 176 | 12 | 31040226 |
| Pubmed | PMS1 RAP1GAP SETX SAMD9 ATRX NACA POLRMT SMC2 ITPR1 DST PRRC2C ZNF638 CRYBG3 RIOK2 | 6.35e-06 | 650 | 176 | 14 | 38777146 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | ANKRD13B RPGRIP1L HSPH1 NACA OBSCN NUP205 EXOC5 JUP NPHP3 SAC3D1 PRKDC CPLANE1 GCN1 | 6.69e-06 | 564 | 176 | 13 | 21565611 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | U2SURP HSPH1 NACA CD55 APOB LARP4 ITPR1 JUP DST TPX2 UTP20 PRKDC GNAS RIOK2 TOP1 DYNC1H1 RBM17 | 7.32e-06 | 949 | 176 | 17 | 36574265 |
| Pubmed | CTTNBP2 ANK3 NACC1 ARHGEF18 ZNF318 EDC4 SMC2 ZNF462 UBA1 DST NF1 PRRC2C LRP1 PLCB1 ADGRA1 HERC2 DYNC1H1 | 8.85e-06 | 963 | 176 | 17 | 28671696 | |
| Pubmed | NACC1 POLRMT ZNF318 ZNF462 JUP DST ALMS1 LRP1 KIF14 CRYBG3 GCN1 | 1.03e-05 | 418 | 176 | 11 | 34709266 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 1.31e-05 | 211 | 176 | 8 | 17314511 | |
| Pubmed | Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. | 1.49e-05 | 10 | 176 | 3 | 19826009 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 1.55e-05 | 104 | 176 | 6 | 36055981 | |
| Pubmed | 1.55e-05 | 104 | 176 | 6 | 9205841 | ||
| Pubmed | 1.57e-05 | 284 | 176 | 9 | 29459677 | ||
| Pubmed | SAMD9 HSPH1 NACA NARS1 SMC2 JUP UBA1 NF1 SH3PXD2A PRKDC GNAS CDC27 GCN1 TOP1 DYNC1H1 | 1.59e-05 | 803 | 176 | 15 | 36517590 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATRX POLRMT ZNF318 LARP4 ITPR1 NUP205 NF1 TPX2 NUP133 HERC2 CDC27 | 1.66e-05 | 440 | 176 | 11 | 34244565 |
| Pubmed | 1.95e-05 | 223 | 176 | 8 | 20020773 | ||
| Pubmed | SMCHD1 HSPH1 AHSA1 NUP205 UBA1 PRRC2C NUP133 PRKDC GNAS CDC27 GCN1 DYNC1H1 | 1.96e-05 | 534 | 176 | 12 | 35032548 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19403693 | ||
| Pubmed | Obscurin is a ligand for small ankyrin 1 in skeletal muscle. | 2.55e-05 | 2 | 176 | 2 | 12631729 | |
| Pubmed | SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies. | 2.55e-05 | 2 | 176 | 2 | 29535429 | |
| Pubmed | Molecular approach in the study of Alström syndrome: analysis of ten Spanish families. | 2.55e-05 | 2 | 176 | 2 | 22876109 | |
| Pubmed | [Pancytopenia in children caused by SAMD9/9L mutation: 5 cases report and literature review]. | 2.55e-05 | 2 | 176 | 2 | 37357006 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29447249 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17407603 | ||
| Pubmed | The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass. | 2.55e-05 | 2 | 176 | 2 | 24550008 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28386233 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 31363052 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 3646943 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14578206 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28842428 | ||
| Pubmed | Viral host range factors antagonize pathogenic SAMD9 and SAMD9L variants. | 2.55e-05 | 2 | 176 | 2 | 36894052 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19002483 | ||
| Pubmed | Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes. | 2.55e-05 | 2 | 176 | 2 | 30322869 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23583712 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 26578593 | ||
| Pubmed | STAT6 and LRP1 polymorphisms are associated with food allergen sensitization in Mexican children. | 2.55e-05 | 2 | 176 | 2 | 22534531 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27503326 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34621053 | ||
| Pubmed | Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. | 2.55e-05 | 2 | 176 | 2 | 20924105 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 33731850 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29054606 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17720975 | ||
| Pubmed | Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans. | 2.55e-05 | 2 | 176 | 2 | 16327289 | |
| Pubmed | Kir6.2-deficient mice develop somatosensory dysfunction and axonal loss in the peripheral nerves. | 2.55e-05 | 2 | 176 | 2 | 35005553 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 37341850 | ||
| Pubmed | BRIP1 SAMD9 NACA SMC2 LARP4 CTTNBP2NL DST KIF14 PLPBP CRYBG3 ELP4 | 3.15e-05 | 472 | 176 | 11 | 38943005 | |
| Pubmed | PMS1 SMCHD1 NACA PIWIL4 APOB EDC4 MDH2 ITPR1 NUP205 TPX2 ZNF638 KIF14 DYNC1H1 RBM17 | 3.28e-05 | 754 | 176 | 14 | 35906200 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX NACC1 POLRMT REV3L SMC2 NUP205 PRRC2C TPX2 NUP133 LRP1 UTP20 TAF5L CDC27 DYNC1H1 ANKRD20A1 | 3.36e-05 | 857 | 176 | 15 | 25609649 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SMCHD1 U2SURP HSPH1 NACA PBK NARS1 MDH2 SMC2 LARP4 LRRC8D JUP UBA1 PRRC2C ZNF638 PLPBP PRKDC RIOK2 GCN1 TOP1 DYNC1H1 | 3.52e-05 | 1415 | 176 | 20 | 28515276 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 3.56e-05 | 394 | 176 | 10 | 27248496 | |
| Pubmed | 3.77e-05 | 179 | 176 | 7 | 19074885 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 3.77e-05 | 179 | 176 | 7 | 36261009 | |
| Pubmed | 3.90e-05 | 180 | 176 | 7 | 24104479 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EDC3 GNPTAB HSPH1 PBK CD55 RNF213 ADAM10 LRRC8D ITPR1 JUP UBA1 NF1 PVR TPX2 LRP1 UTP20 SMPD1 MTARC1 | 4.19e-05 | 1201 | 176 | 18 | 35696571 |
| Pubmed | 4.20e-05 | 322 | 176 | 9 | 26514267 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | EDC3 RPGRIP1L ANK3 ATRX DGKE SMC2 NUP205 EXOC5 UBA1 ASAP2 NPHP3 NF1 SH3PXD2A NUP133 ZNF638 CDC27 GCN1 DYNC1H1 MTARC1 | 4.42e-05 | 1321 | 176 | 19 | 27173435 |
| Pubmed | 4.51e-05 | 251 | 176 | 8 | 29778605 | ||
| Pubmed | EDC3 SETX RPGRIP1L ANK3 LRRK2 RNF213 APOB ZNF318 TASOR2 DST ZNF638 PRKDC GCN1 DYNC1H1 | 4.54e-05 | 777 | 176 | 14 | 35844135 | |
| Interaction | RNF123 interactions | USP17L7 PMS1 MROH9 EDC3 SETX ANK1 NACC1 HSPH1 OBSCN NARS1 RNF213 ANKRD20A3P REV3L CTTNBP2NL ESCO1 NUP205 JUP SAMD9L DST PLXNA4 UTP20 PRKDC DYNC1H1 ELP4 | 1.06e-07 | 824 | 169 | 24 | int:RNF123 |
| Interaction | GRWD1 interactions | U2SURP HSPH1 NACA POLRMT MDH2 SMC2 KMT2E UBA1 LPIN2 KIF14 PRKDC CDC6 GCN1 TOP1 DYNC1H1 | 1.08e-06 | 390 | 169 | 15 | int:GRWD1 |
| Interaction | SIRT7 interactions | SMCHD1 U2SURP POLRMT NARS1 ZNF318 EDC4 LARP4 TASOR2 NUP205 DST NF1 PRRC2C NUP133 ZNF638 KIF14 UTP20 PRKDC HERC2 GCN1 TOP1 DYNC1H1 | 1.18e-06 | 744 | 169 | 21 | int:SIRT7 |
| Interaction | SLX4 interactions | PMS1 BRIP1 EDC3 ATRX SMCHD1 HSPH1 NACA ZNF318 REV3L ZNF518A ZNF462 JUP UBA1 TPX2 PLPBP PRKDC GCN1 DYNC1H1 | 1.59e-06 | 572 | 169 | 18 | int:SLX4 |
| Interaction | NAA40 interactions | PMS1 EDC3 ATRX NACC1 SMCHD1 U2SURP HSPH1 NACA ZNF318 EDC4 MDH2 AHSA1 JUP UBA1 DST ALMS1 PRRC2C TPX2 NUP133 ZNF638 PRKDC GCN1 TOP1 RBM17 | 2.27e-06 | 978 | 169 | 24 | int:NAA40 |
| Interaction | KCNA3 interactions | EDC3 ANK3 ICE2 HSPH1 NACA LRRK2 NARS1 RNF213 SMC2 JUP UBA1 ASAP2 DST PRRC2C PRKDC CRYBG3 CDC27 GCN1 TOP1 DYNC1H1 DOP1A TDRD12 | 3.95e-06 | 871 | 169 | 22 | int:KCNA3 |
| Interaction | HECTD1 interactions | RPGRIP1L SMCHD1 U2SURP HSPH1 NACA POLRMT SMC2 LARP4 NUP205 EXOC5 SH3PXD2A PRRC2C TPX2 NUP133 UTP20 PRKDC HERC2 CDC6 CDC27 RIOK2 GCN1 TOP1 RBM17 | 8.36e-06 | 984 | 169 | 23 | int:HECTD1 |
| Interaction | NEK4 interactions | KCNH7 RPGRIP1L SMCHD1 U2SURP LRRK2 PIWIL4 APOB CTTNBP2NL ZNF462 DST SH3PXD2A ASXL3 PRKDC HERC2 TOP1 ALPK2 RBM17 | 8.43e-06 | 582 | 169 | 17 | int:NEK4 |
| Interaction | SUMO2 interactions | SETX ATRX SMCHD1 NACA LRRK2 NARS1 RNF213 EDC4 SMC2 UBA1 DST TPX2 ZNF638 PRKDC LTK GCN1 DYNC1H1 | 1.03e-05 | 591 | 169 | 17 | int:SUMO2 |
| Interaction | CCDC8 interactions | NIBAN1 SMCHD1 NACA APOB ZNF318 MDH2 SMC2 NUP205 JUP UBA1 DST NF1 UTP20 PRKDC GNAS HERC2 GCN1 DYNC1H1 | 1.06e-05 | 656 | 169 | 18 | int:CCDC8 |
| Interaction | ANKRD20A4P interactions | 1.14e-05 | 6 | 169 | 3 | int:ANKRD20A4P | |
| Interaction | PLEC interactions | CTTNBP2 ANK3 NACA LRRK2 ASH1L MDH2 SMC2 STAT6 ITPR1 JUP DST TBCK KIF14 HERC2 | 1.67e-05 | 430 | 169 | 14 | int:PLEC |
| Interaction | TESK2 interactions | 1.76e-05 | 97 | 169 | 7 | int:TESK2 | |
| Interaction | MTCL3 interactions | 1.79e-05 | 39 | 169 | 5 | int:MTCL3 | |
| Interaction | ANKRD20A2P interactions | 1.98e-05 | 7 | 169 | 3 | int:ANKRD20A2P | |
| Interaction | OBSL1 interactions | SMCHD1 U2SURP EDC4 MDH2 LARP4 TASOR2 NUP205 JUP UBA1 DST NUP133 ZNF638 KIF14 UTP20 PRKDC HERC2 GCN1 TOP1 DYNC1H1 ALPK2 RBM17 | 2.27e-05 | 902 | 169 | 21 | int:OBSL1 |
| Interaction | CIT interactions | SETX SMCHD1 NACA LRRK2 ASH1L CD55 NARS1 RNF213 APOB EDC4 MDH2 ADAM10 NUP205 JUP UBA1 ALMS1 PRRC2C TPX2 NUP133 ZNF638 KIF14 UTP20 PRKDC GNAS GCN1 TOP1 DYNC1H1 RBM17 | 2.83e-05 | 1450 | 169 | 28 | int:CIT |
| Interaction | EPHA1 interactions | 3.04e-05 | 235 | 169 | 10 | int:EPHA1 | |
| Interaction | CDC5L interactions | PMS1 SETX RBM45 SMCHD1 U2SURP EDC4 SMC2 EXOC5 DST NF1 TPX2 ZNF638 KIF14 PRKDC GNAS CDC27 GCN1 TOP1 DYNC1H1 RBM17 | 3.37e-05 | 855 | 169 | 20 | int:CDC5L |
| Interaction | OC90 interactions | 4.45e-05 | 24 | 169 | 4 | int:OC90 | |
| Interaction | BRCA1 interactions | MMS22L BRIP1 SETX RBM45 SMCHD1 HSPH1 NACA OBSCN MDH2 ITPR1 JUP UBA1 DST NF1 ALMS1 PRKAA2 TPX2 NUP133 PRKDC TAF5L HERC2 CDC27 GCN1 TOP1 DYNC1H1 | 4.50e-05 | 1249 | 169 | 25 | int:BRCA1 |
| Interaction | HDAC4 interactions | EDC3 THSD7A ATRX NACC1 SMCHD1 NARS1 REV3L MDH2 ITPR1 NF1 SH3PXD2A PRRC2C SLIT1 ZNF638 PLCB1 NIT1 HERC2 TOP1 | 5.56e-05 | 744 | 169 | 18 | int:HDAC4 |
| Interaction | ATOH1 interactions | 5.72e-05 | 80 | 169 | 6 | int:ATOH1 | |
| Interaction | TNFSF13B interactions | 6.56e-05 | 119 | 169 | 7 | int:TNFSF13B | |
| Interaction | MAGEA9 interactions | 6.72e-05 | 208 | 169 | 9 | int:MAGEA9 | |
| Interaction | KIF20A interactions | SETX POLRMT CD55 APOB ZNF318 ITPR1 NUP205 ZNF462 JUP SAMD9L ALMS1 TPX2 NUP133 ZNF638 KIF14 PRKDC CRYBG3 GNAS HERC2 GCN1 TOP1 RBM17 | 7.15e-05 | 1052 | 169 | 22 | int:KIF20A |
| Interaction | THSD7A interactions | 7.20e-05 | 27 | 169 | 4 | int:THSD7A | |
| Interaction | G3BP1 interactions | RBM45 ITGA2B EDC4 LARP4 ADAM10 CTTNBP2NL NUP205 JUP UBA1 DST PRRC2C PRKAA2 TPX2 NUP133 ZNF638 KIF14 RIOK2 GCN1 DYNC1H1 | 7.74e-05 | 835 | 169 | 19 | int:G3BP1 |
| Interaction | TRIM37 interactions | EDC3 RPGRIP1L U2SURP NACA PBK ARHGEF18 ZNF318 STIL ALMS1 ARNT2 LRP1 KIF14 CEP152 ANKRD12 PRKDC GNAS | 8.37e-05 | 630 | 169 | 16 | int:TRIM37 |
| Interaction | C19orf38 interactions | 8.59e-05 | 86 | 169 | 6 | int:C19orf38 | |
| Interaction | ANKRD20A1 interactions | 9.10e-05 | 11 | 169 | 3 | int:ANKRD20A1 | |
| Interaction | NPTN interactions | MMS22L SETX RNF213 EDC4 RANBP17 EXOC5 KIF14 UTP20 GCN1 DOP1A | 1.24e-04 | 278 | 169 | 10 | int:NPTN |
| Interaction | DCPS interactions | SMCHD1 U2SURP EDC4 ITPR1 NUP205 NUP133 UTP20 CEP152 PRKDC CDC27 TOP1 DYNC1H1 | 1.27e-04 | 394 | 169 | 12 | int:DCPS |
| Interaction | YWHAH interactions | RAP1GAP EDC3 SETX RPGRIP1L HSPH1 LRRK2 STIL EDC4 JUP UBA1 DST NF1 ALMS1 SH3PXD2A PRRC2C PRKAA2 ZNF638 KIF14 MTBP CEP152 CRYBG3 DOP1A | 1.40e-04 | 1102 | 169 | 22 | int:YWHAH |
| Interaction | JAK3 interactions | 1.52e-04 | 136 | 169 | 7 | int:JAK3 | |
| Interaction | TBK1 interactions | ATRX NACC1 U2SURP APOB STIL DST PRRC2C DTX4 TPX2 CEP152 HERC2 TOP1 | 1.54e-04 | 402 | 169 | 12 | int:TBK1 |
| Interaction | NPHP4 interactions | ANKRD13B RPGRIP1L NACA OBSCN NUP205 JUP SAC3D1 PRKDC CPLANE1 | 1.75e-04 | 236 | 169 | 9 | int:NPHP4 |
| GeneFamily | Ankyrin repeat domain containing | ANKRD13B CTTNBP2 ANK1 ANK3 ANKRD20A2P ANKRD20A3P ASAP2 ANKRD20A4P ANKRD36 ANKRD12 ANKRD20A1 | 3.45e-07 | 242 | 113 | 11 | 403 |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.35e-04 | 42 | 113 | 4 | 602 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.82e-04 | 394 | 113 | 10 | 471 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 SETX ATRX SMCHD1 U2SURP STIL REV3L LARP4 ADAM10 ITPR1 ASAP2 DST PRRC2C ARNT2 NUP133 ZNF638 KIF14 UTP20 CRYBG3 CDC27 TOP1 | 2.75e-07 | 856 | 174 | 21 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SETX CTTNBP2 ICE2 SMCHD1 GNPTAB HSPH1 PBK CD55 NARS1 REV3L SMC2 TASOR2 ITPR1 ZNF638 KIF14 CPLANE1 RIOK2 RBM17 | 4.20e-07 | 656 | 174 | 18 | M18979 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | RAP1GAP TENT4A SMCHD1 GNPTAB HSPH1 CASP1 CD55 REV3L STAT6 ASAP2 NF1 PRRC2C LRP1 KIF14 C1R PRKDC GNAS HERC2 CDC27 | 1.42e-06 | 790 | 174 | 19 | M12490 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PMS1 ATRX SMCHD1 U2SURP STIL REV3L LARP4 ADAM10 ASAP2 DST PRRC2C ZNF638 KIF14 CDC27 | 3.05e-06 | 466 | 174 | 14 | M13522 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.44e-06 | 180 | 174 | 9 | M8239 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN | 6.87e-06 | 196 | 174 | 9 | M4267 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN | 7.46e-06 | 198 | 174 | 9 | M4264 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN | 8.09e-06 | 200 | 174 | 9 | M8490 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 8.09e-06 | 200 | 174 | 9 | M5901 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_UP | 8.76e-06 | 153 | 174 | 8 | M18058 | |
| Coexpression | ONDER_CDH1_TARGETS_1_DN | 1.89e-05 | 170 | 174 | 8 | M6822 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 2.46e-05 | 230 | 174 | 9 | M11563 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | BRIP1 SAMD9 DCDC1 ANK3 TENT4A SMCHD1 CASP1 CMPK2 RNF213 PIWIL4 NSUN7 ZNF462 JUP SAMD9L ARNT2 TPX2 LPIN2 C1R DOP1A | 2.72e-05 | 973 | 174 | 19 | M41080 |
| Coexpression | DESCARTES_ORGANOGENESIS_PRIMITIVE_ERYTHROID_LINEAGE | ANK1 KATNB1 NARS1 CMPK2 ANKRD20A3P ANKRD20A8P TATDN3 ANKRD20A4P ART4 TPX2 KIF14 TAF5L ANKRD20A1 | 2.98e-05 | 497 | 174 | 13 | MM3640 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 3.20e-05 | 183 | 174 | 8 | M2993 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.43e-05 | 300 | 174 | 10 | M8702 | |
| Coexpression | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER | 4.31e-05 | 140 | 174 | 7 | M15664 | |
| Coexpression | GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP | 4.51e-05 | 141 | 174 | 7 | M407 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN | 5.02e-05 | 195 | 174 | 8 | M4292 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | HSPH1 NACA STIL SMC2 LARP4 AHSA1 NUP205 NF1 PRRC2C TPX2 KIF14 UTP20 PRKDC TAF5L CDC6 TOP1 | 5.11e-05 | 761 | 174 | 16 | M11961 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ANKRD13B MMS22L BRIP1 KCNH7 PBK STIL REV3L SMC2 NUP205 RANBP17 ALMS1 ARNT2 TPX2 KIF14 CDC6 | 5.17e-05 | 680 | 174 | 15 | MM456 |
| Coexpression | KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP | TRIB2 TENT4A NACA KATNB1 NARS1 ARHGEF18 AHSA1 CRYM UBA1 DTX4 SLIT1 ARNT2 LPIN2 GNAS DYNC1H1 | 5.17e-05 | 680 | 174 | 15 | M2107 |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 5.40e-05 | 197 | 174 | 8 | M8983 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP | 5.40e-05 | 197 | 174 | 8 | M7930 | |
| Coexpression | GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP | 5.40e-05 | 197 | 174 | 8 | M9250 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | PMS1 MMS22L BRIP1 PBK CMPK2 STIL SMC2 LARP4 NUP205 JUP ALMS1 TPX2 KIF14 SAC3D1 CEP152 ANKRD36 CDC6 CDC27 | 5.67e-05 | 939 | 174 | 18 | M45768 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 5.79e-05 | 199 | 174 | 8 | M5893 | |
| Coexpression | GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN | 6.00e-05 | 200 | 174 | 8 | M9844 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 6.00e-05 | 200 | 174 | 8 | M7449 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP | 6.00e-05 | 200 | 174 | 8 | M4442 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MMS22L BRIP1 PBK STIL SMC2 NUP205 RANBP17 TPX2 KIF14 MTBP CDC6 | 8.31e-05 | 402 | 174 | 11 | MM454 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | MMS22L BRIP1 PBK CMPK2 SMC2 TPX2 PLCB1 KIF14 SAC3D1 CEP152 ANKRD36 CDC6 | 8.96e-05 | 478 | 174 | 12 | M45785 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | SEMA4D RAP1GAP BRIP1 RPGRIP1L TENT4A CMPK2 FAM120AOS STIL SMC2 NPHP3 DST PRKAA2 CUZD1 KIF14 GNAS HERC2 TOP1 | 9.86e-05 | 892 | 174 | 17 | M18120 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | PMS1 SAMD9 ATRX U2SURP STIL SMC2 ADAM10 EXOC5 PVR TPX2 PLCB1 KIF14 ZNF616 RIOK2 TOP1 | 9.92e-05 | 721 | 174 | 15 | M10237 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 1.08e-04 | 162 | 174 | 7 | M45037 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 1.12e-04 | 163 | 174 | 7 | M8235 | |
| Coexpression | GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN | 1.41e-04 | 169 | 174 | 7 | M8937 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | THSD7A ANK1 ANK3 ATRX GNPTAB LRRK2 DGKE ZNF318 REV3L KMT2E ZNF462 SH3PXD2A ASXL3 PRKAA2 ARNT2 PLXNA4 ANKRD36 ANKRD12 DOP1A | 1.48e-04 | 1106 | 174 | 19 | M39071 |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN | 1.94e-04 | 178 | 174 | 7 | M2950 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | KANSL1L SETX CTTNBP2 RBM45 SMCHD1 PBK SMC2 ARNT2 PLCB1 ZNF616 CDC6 | 2.14e-04 | 448 | 174 | 11 | MM1044 |
| Coexpression | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP | 2.45e-04 | 185 | 174 | 7 | M3155 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | 2.58e-04 | 458 | 174 | 11 | M8520 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS | 2.60e-04 | 85 | 174 | 5 | M43623 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 2.62e-04 | 187 | 174 | 7 | M2984 | |
| Coexpression | FISCHER_DREAM_TARGETS | MMS22L BRIP1 SMCHD1 PBK STIL SMC2 ZNF518A NUP205 ALMS1 TTLL4 TPX2 KIF14 MTBP CEP152 PRKDC CDC6 TOP1 | 2.62e-04 | 969 | 174 | 17 | M149 |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP | 3.07e-04 | 192 | 174 | 7 | M9509 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | BRIP1 ATRX ICE2 KATNB1 PBK STIL SMC2 TATDN3 ALMS1 TPX2 NUP133 MTBP PRKDC CDC6 | 3.10e-04 | 714 | 174 | 14 | M1744 |
| Coexpression | DESCARTES_FETAL_PANCREAS_ACINAR_CELLS | 3.39e-04 | 90 | 174 | 5 | M40267 | |
| Coexpression | LIU_SOX4_TARGETS_UP | 3.40e-04 | 139 | 174 | 6 | M17450 | |
| Coexpression | GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 3.48e-04 | 196 | 174 | 7 | M7672 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 3.59e-04 | 197 | 174 | 7 | M7543 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 3.59e-04 | 197 | 174 | 7 | M8980 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 3.70e-04 | 198 | 174 | 7 | M9407 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN | 3.70e-04 | 198 | 174 | 7 | M6033 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 3.93e-04 | 200 | 174 | 7 | M3580 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN | 3.93e-04 | 200 | 174 | 7 | M8257 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 3.93e-04 | 200 | 174 | 7 | M5030 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN | 3.93e-04 | 200 | 174 | 7 | M4269 | |
| Coexpression | GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP | 3.93e-04 | 200 | 174 | 7 | M4110 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP | 3.93e-04 | 200 | 174 | 7 | M9281 | |
| Coexpression | GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP | 4.15e-04 | 94 | 174 | 5 | M18983 | |
| Coexpression | HECKER_IFNB1_TARGETS | 4.35e-04 | 95 | 174 | 5 | M3010 | |
| Coexpression | CROONQUIST_IL6_DEPRIVATION_DN | 4.35e-04 | 95 | 174 | 5 | M18506 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | PMS1 BRIP1 ICE2 U2SURP PBK RNF213 SMC2 NUP205 NF1 PRRC2C TTLL4 ARNT2 TPX2 NUP133 KIF14 PLPBP SAC3D1 CEP152 PRKDC CDC6 CDC27 | 4.42e-04 | 1407 | 174 | 21 | M14427 |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 4.42e-04 | 146 | 174 | 6 | M9372 | |
| Coexpression | BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP | 4.43e-04 | 204 | 174 | 7 | M34006 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SETX NACC1 HSPH1 POU3F3 STIL SMC2 LARP4 ESCO1 ZNF518A EXOC5 ALMS1 PRRC2C DTX4 TPX2 ZNF638 KIF14 MTBP PRKDC TOP1 RBM17 | 7.86e-09 | 532 | 167 | 20 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | ATRX ICE2 GNPTAB ASH1L SMC2 ADAM10 CTTNBP2NL TPX2 RSPO2 ZNF616 PLPBP ADGRA1 SLITRK6 CPLANE1 TOP1 | 1.07e-08 | 291 | 167 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | KANSL1L CTTNBP2 ATRX RBM45 GRK4 ASH1L CD55 RNF213 ZNF318 SMC2 KMT2E LARP4 ESCO1 ZNF518A PRRC2C RSPO2 C1R ZNF616 ANKRD12 CPLANE1 TOP1 TDRD12 | 2.10e-07 | 778 | 167 | 22 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SETX THSD7A ATRX HSPH1 SMC2 ZNF518A DST ALMS1 PRRC2C TPX2 ZNF638 MTBP PRKDC RIOK2 TOP1 RBM17 | 9.76e-07 | 469 | 167 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | PMS1 BRIP1 SETX ICE2 HSPH1 RNF213 PIWIL4 ZNF318 AASDH ZNF518A TASOR2 NUP205 RANBP17 ALMS1 NUP133 KIF14 UTP20 ANKRD12 PRKDC CPLANE1 TDRD12 | 1.64e-06 | 810 | 167 | 21 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ANKRD13B KANSL1L RAP1GAP SETX ATRX ICE2 GRK4 GNPTAB HSPH1 STIL REV3L SMC2 CTTNBP2NL LEPR ZNF518A ZNF462 RANBP17 CRYM ALMS1 TPX2 ZNF638 ZNF616 ANKRD12 SLITRK6 CPLANE1 CDC27 TOP1 | 1.69e-06 | 1252 | 167 | 27 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | ANK1 ICE2 POLRMT SMC2 LRRC8D CTTNBP2NL ZNF462 CRYM ALMS1 ASXL3 ZNF638 RSPO2 ZNF616 SLITRK6 TOP1 RBM17 | 1.82e-06 | 492 | 167 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PMS1 MMS22L BRIP1 SETX ICE2 GRK4 ZNF318 LARP4 ESCO1 ZNF518A TASOR2 RANBP17 ALMS1 SNX25 NUP133 KIF14 ANKRD12 PRKDC CPLANE1 DOP1A TDRD12 | 1.99e-06 | 820 | 167 | 21 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | NIBAN1 ICE2 POLRMT RNF213 STIL SMC2 CTTNBP2NL ASXL3 ZNF638 RSPO2 SLITRK6 TOP1 RBM17 | 2.30e-06 | 331 | 167 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ATRX RBM45 ICE2 GRK4 ASH1L RNF213 ZNF318 SMC2 KMT2E LARP4 ESCO1 ZNF518A TASOR2 EXOC5 ALMS1 ZNF616 ANKRD12 CPLANE1 TOP1 TDRD12 | 3.24e-06 | 776 | 167 | 20 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | KANSL1L NIBAN1 RAP1GAP SETX ANK1 ATRX LRRK2 RNF213 STIL REV3L SH3PXD2A ASXL3 ZNF638 PLCB1 RSPO2 ANKRD12 SLITRK6 TOP1 DOP1A | 6.62e-06 | 744 | 167 | 19 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | CTTNBP2 ATRX ASH1L SMC2 PRRC2C C1R ZNF616 ANKRD12 CPLANE1 TOP1 | 6.63e-06 | 210 | 167 | 10 | gudmap_developingGonad_e18.5_ovary_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ATRX ICE2 REV3L ADAM10 LRRC8D ZNF518A ALMS1 TPX2 RSPO2 ADGRA1 PRKDC TOP1 | 6.84e-06 | 311 | 167 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RPGRIP1L THSD7A ATRX GNPTAB HSPH1 ASH1L POU3F3 ADAM10 LRRC8D ZNF518A ALMS1 DTX4 TPX2 ZNF616 PLPBP ADGRA1 PXYLP1 PRKDC TOP1 GGNBP1 | 8.94e-06 | 831 | 167 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | TRIB2 ANK1 ATRX ICE2 GNPTAB ASH1L CD55 REV3L SMC2 ADAM10 CTTNBP2NL CRYM NPHP3 ASXL3 TPX2 RSPO2 ZNF616 PLPBP ADGRA1 SLITRK6 CPLANE1 TOP1 | 1.00e-05 | 985 | 167 | 22 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | THSD7A ATRX ICE2 U2SURP HSPH1 POU3F3 REV3L LARP4 ADAM10 LRRC8D ZNF518A ALMS1 DTX4 TPX2 RSPO2 UTP20 SAC3D1 ADGRA1 PXYLP1 PRKDC CDC6 TOP1 | 1.07e-05 | 989 | 167 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | ATRX RBM45 ASH1L ZNF318 SMC2 LARP4 ESCO1 ZNF518A EXOC5 ZNF616 ANKRD12 CPLANE1 TDRD12 | 1.09e-05 | 382 | 167 | 13 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.65e-05 | 110 | 167 | 7 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | PMS1 SEMA4D MMS22L BRIP1 SETX RNF213 LARP4 ZNF518A TASOR2 NUP205 ZNF462 RANBP17 ALMS1 NUP133 KIF14 UTP20 PRKDC CPLANE1 TDRD12 | 2.65e-05 | 822 | 167 | 19 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | MMS22L BRIP1 PBK DGKE STIL SMC2 NUP205 ALMS1 TPX2 NUP133 KIF14 MTBP CDC6 | 2.73e-05 | 417 | 167 | 13 | GSM399403_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | NIBAN1 ANK1 ICE2 POLRMT RNF213 STIL SMC2 LRRC8D CTTNBP2NL ZNF462 EXOC5 CRYM ALMS1 ASXL3 ZNF638 PLCB1 RSPO2 ZNF616 SLITRK6 TOP1 RBM17 | 2.90e-05 | 978 | 167 | 21 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | KANSL1L NIBAN1 RAP1GAP ICE2 LRRK2 POLRMT RNF213 STIL SMC2 KMT2E CTTNBP2NL ASXL3 ZNF638 RSPO2 ANKRD12 SLITRK6 TOP1 DOP1A RBM17 | 3.23e-05 | 834 | 167 | 19 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | KANSL1L SETX ANK3 ATRX ICE2 SMCHD1 GRK4 GNPTAB HSPH1 POLRMT STIL SMC2 CTTNBP2NL ZNF518A ZNF462 ALMS1 ASXL3 SNX25 TPX2 ZNF616 MTBP SLITRK6 TOP1 RBM17 | 4.06e-05 | 1241 | 167 | 24 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | EDC3 CTTNBP2 THSD7A CTTNBP2NL LEPR TASOR2 ZNF462 CRYM ASAP2 DST ASXL3 TTLL4 ARNT2 NUP133 RSPO2 PXYLP1 SLITRK6 LY75 ELP4 | 4.18e-05 | 850 | 167 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PMS1 ANKRD13B MMS22L SETX ATRX ICE2 SMCHD1 GRK4 HSPH1 PBK STIL REV3L SMC2 ZNF462 EXOC5 ALMS1 TPX2 ZNF616 UTP20 MTBP CPLANE1 CDC27 TOP1 RBM17 | 4.97e-05 | 1257 | 167 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | DRC7 KANSL1L MMS22L IL31RA BRIP1 PBK STIL SMC2 ITPR1 TPX2 KIF14 CDC6 | 6.04e-05 | 388 | 167 | 12 | GSM538352_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | NIBAN1 SETX CTTNBP2 ANK3 ATRX REV3L SMC2 ADAM10 CTTNBP2NL TASOR2 DST ARNT2 RSPO2 HERC2 SLITRK6 CPLANE1 CDC27 GCN1 | 6.81e-05 | 806 | 167 | 18 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PMS1 ANKRD13B MMS22L SETX ATRX ICE2 SMCHD1 GRK4 HSPH1 PBK POU3F3 STIL REV3L SMC2 ZNF462 EXOC5 CRYM ALMS1 TPX2 ZNF616 UTP20 MTBP CPLANE1 CDC27 TOP1 RBM17 | 7.39e-05 | 1459 | 167 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | TRIB2 SETX HSPH1 CD55 REV3L TASOR2 SAMD9L PRRC2C PRKDC LY75 DOP1A | 7.44e-05 | 336 | 167 | 11 | GSM538413_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | CTTNBP2 ATRX RBM45 HSPH1 ASH1L POU3F3 SMC2 KMT2E LARP4 ESCO1 ZNF462 EXOC5 PRRC2C ASXL3 ZNF616 CDC6 CPLANE1 TOP1 | 7.84e-05 | 815 | 167 | 18 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | SETX ANK3 ATRX DGKE POU3F3 REV3L SMC2 PRRC2C ARNT2 CPLANE1 GCN1 | 8.05e-05 | 339 | 167 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | NIBAN1 SETX CTTNBP2 ANK3 REV3L DST ARNT2 RSPO2 HERC2 SLITRK6 CPLANE1 GCN1 | 9.72e-05 | 408 | 167 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | ATRX RBM45 ASH1L RNF213 SMC2 LARP4 ESCO1 EXOC5 ASXL3 ZNF616 TOP1 TDRD12 | 9.95e-05 | 409 | 167 | 12 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.15e-04 | 186 | 167 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | KANSL1L NIBAN1 CTTNBP2 ATRX ICE2 GRK4 POLRMT CD55 POU3F3 SMC2 KMT2E LEPR DST SH3PXD2A ASXL3 SLIT1 ZNF616 PLPBP ANKRD12 SLITRK6 CPLANE1 DOP1A | 1.25e-04 | 1166 | 167 | 22 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | ATRX RBM45 GAS6 ASH1L CD55 RNF213 PIWIL4 SMC2 LARP4 ESCO1 ZNF518A PRRC2C PLXNA4 RSPO2 ZNF616 ANKRD12 CPLANE1 | 1.26e-04 | 770 | 167 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.30e-04 | 298 | 167 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.44e-04 | 192 | 167 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | SETX ANK3 ATRX REV3L SMC2 ADAM10 ARNT2 HERC2 CPLANE1 CDC27 GCN1 | 1.69e-04 | 369 | 167 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.83e-04 | 105 | 167 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | ATRX RBM45 ASH1L SMC2 KMT2E ESCO1 ZNF462 PRRC2C ASXL3 DTX4 LRP1 C1R ZNF616 ANKRD12 SLITRK6 CPLANE1 TOP1 | 1.95e-04 | 799 | 167 | 17 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 2.03e-04 | 107 | 167 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | KANSL1L SETX ANK3 ATRX ICE2 SMCHD1 GRK4 GNPTAB HSPH1 POLRMT STIL SMC2 CTTNBP2NL ZNF518A ZNF462 CRYM ALMS1 ASXL3 SNX25 TPX2 ZNF616 MTBP SLITRK6 TOP1 RBM17 | 2.09e-04 | 1468 | 167 | 25 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | ATRX RBM45 SMCHD1 ASH1L RNF213 SMC2 KMT2E LARP4 ESCO1 EXOC5 PRRC2C ASXL3 ZNF616 ANKRD12 CPLANE1 TOP1 TDRD12 | 2.09e-04 | 804 | 167 | 17 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | ATRX RBM45 ASH1L RNF213 ZNF318 SMC2 KMT2E LARP4 ESCO1 ZNF462 PRRC2C ASXL3 ZNF638 ZNF616 CPLANE1 TOP1 TDRD12 | 2.16e-04 | 806 | 167 | 17 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.18e-04 | 259 | 167 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | MMS22L BRIP1 TRIB2 LRRK2 PBK STIL SMC2 SNX25 TPX2 KIF14 CDC6 | 2.18e-04 | 380 | 167 | 11 | GSM538207_500 |
| CoexpressionAtlas | pancreas | 2.27e-04 | 70 | 167 | 5 | pancreas | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | IL13RA1 NIBAN1 LRRK2 CMPK2 RNF213 CTTNBP2NL JUP DST PVR LRP1 LY75 | 2.39e-04 | 384 | 167 | 11 | GSM605820_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | MMS22L BRIP1 ZNF318 ZNF518A TASOR2 RANBP17 ALMS1 KIF14 PRKDC CPLANE1 TDRD12 | 2.44e-04 | 385 | 167 | 11 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | ATRX RBM45 ASH1L CD55 ZNF318 LARP4 ESCO1 RSPO2 ZNF616 ANKRD12 CPLANE1 | 2.55e-04 | 387 | 167 | 11 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | ATRX RBM45 GRK4 ASH1L RNF213 ZNF318 KMT2E LARP4 ESCO1 ZNF616 CPLANE1 | 2.55e-04 | 387 | 167 | 11 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 2.66e-04 | 266 | 167 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | KANSL1L IL13RA1 NIBAN1 TRIB2 CTTNBP2 ATRX ICE2 GRK4 GAS6 LRRK2 ITGA2B KMT2E LEPR NPHP3 SH3PXD2A SNX25 SLIT1 PLCB1 ANKRD12 SLITRK6 DOP1A | 2.74e-04 | 1148 | 167 | 21 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 2.74e-04 | 327 | 167 | 10 | GSM538380_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.95e-04 | 330 | 167 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | PMS1 BRIP1 SETX HSPH1 PIWIL4 ZNF518A RANBP17 KIF14 UTP20 PRKDC TDRD12 | 3.11e-04 | 396 | 167 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | MMS22L BRIP1 PBK DGKE STIL SMC2 ALMS1 TPX2 NUP133 KIF14 CDC6 | 3.17e-04 | 397 | 167 | 11 | GSM791143_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | CTTNBP2 THSD7A U2SURP HSPH1 POU3F3 CTTNBP2NL ZNF518A TASOR2 ZNF462 CRYM DST NUP133 RSPO2 PXYLP1 SLITRK6 LY75 ELP4 | 3.29e-04 | 836 | 167 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | DRC7 KANSL1L MMS22L IL31RA BRIP1 PBK STIL SMC2 TPX2 KIF14 CDC6 | 3.31e-04 | 399 | 167 | 11 | GSM538345_500 |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | DRC7 IL13RA1 MMS22L IL31RA BRIP1 PBK STIL SMC2 TPX2 HAAO CDC6 | 3.45e-04 | 401 | 167 | 11 | GSM791114_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | ATRX RBM45 ASH1L SMC2 ESCO1 ZNF462 PRRC2C ASXL3 ZNF616 TOP1 TDRD12 | 3.60e-04 | 403 | 167 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | ATRX RBM45 ASH1L SMC2 KMT2E PRRC2C ASXL3 LRP1 ZNF616 CPLANE1 TOP1 | 3.83e-04 | 406 | 167 | 11 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | KANSL1L MMS22L BRIP1 PBK STIL SMC2 NUP205 ALMS1 TPX2 KIF14 CDC6 | 4.08e-04 | 409 | 167 | 11 | GSM399452_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | ATRX RBM45 ASH1L SMC2 KMT2E PRRC2C ASXL3 LRP1 ZNF616 CPLANE1 TOP1 | 4.42e-04 | 413 | 167 | 11 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | PMS1 ANKRD13B ATRX HSPH1 AASDH STIL REV3L SMC2 LRRC8D ZNF462 RANBP17 NPHP3 ALMS1 DTX4 TTLL4 SLIT1 ARNT2 TPX2 LPIN2 KIF14 ZNF616 CPLANE1 TOP1 | 4.68e-04 | 1370 | 167 | 23 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.86e-04 | 230 | 167 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 4.89e-04 | 418 | 167 | 11 | GSM538350_500 | |
| CoexpressionAtlas | B cells, B.T1.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23-, Spleen, avg-3 | TRIB2 LRRK2 CD55 CMPK2 ARHGEF18 ZNF318 ITPR1 SAMD9L SNX25 HAAO | 5.00e-04 | 353 | 167 | 10 | GSM538213_500 |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | TRIB2 SETX CD55 ARHGEF18 RNF213 ZNF318 TASOR2 SAMD9L HAAO LY75 | 5.58e-04 | 358 | 167 | 10 | GSM605909_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.60e-04 | 85 | 167 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | CTTNBP2NL LEPR TASOR2 ZNF462 CRYM ASAP2 DST RSPO2 SLITRK6 LY75 ELP4 | 5.95e-04 | 428 | 167 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | THSD7A HSPH1 POU3F3 KMT2E LARP4 LRRC8D DST ALMS1 DTX4 TPX2 ZNF616 ADGRA1 ANKRD12 DOP1A | 6.82e-04 | 654 | 167 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SETX THSD7A ATRX ICE2 GRK4 HSPH1 PBK STIL SMC2 ZNF462 RANBP17 ALMS1 DTX4 TTLL4 ARNT2 TPX2 KIF14 PXYLP1 TOP1 | 6.95e-04 | 1060 | 167 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SETX THSD7A ATRX ICE2 GRK4 HSPH1 PBK POU3F3 STIL SMC2 IL22RA1 ZNF462 RANBP17 CRYM ALMS1 DTX4 TTLL4 SLIT1 ARNT2 TPX2 KIF14 PXYLP1 TOP1 | 7.23e-04 | 1414 | 167 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | SETX ATRX ASH1L CD55 REV3L SMC2 LARP4 ZNF462 PRRC2C ASXL3 ARNT2 PLCB1 RSPO2 HERC2 SLITRK6 CPLANE1 | 7.51e-04 | 818 | 167 | 16 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.64e-04 | 91 | 167 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.56e-04 | 193 | 167 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 8.83e-04 | 194 | 167 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.03e-03 | 258 | 167 | 8 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | KANSL1L NIBAN1 RAP1GAP ANK1 ATRX RNF213 SH3PXD2A PLCB1 RSPO2 ANKRD12 SLITRK6 TOP1 DOP1A | 1.06e-03 | 607 | 167 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.08e-03 | 201 | 167 | 7 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_100 | 1.17e-03 | 100 | 167 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.18e-03 | 395 | 167 | 10 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | 1.18e-03 | 395 | 167 | 10 | GSM538340_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 1.22e-03 | 150 | 167 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 1.22e-03 | 101 | 167 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 1.25e-03 | 398 | 167 | 10 | GSM538338_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 1.25e-03 | 398 | 167 | 10 | GSM399397_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.26e-03 | 151 | 167 | 6 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RPGRIP1L ATRX ICE2 GNPTAB ASH1L REV3L SMC2 ADAM10 TPX2 ZNF616 PLPBP ADGRA1 CPLANE1 TOP1 GGNBP1 | 1.30e-03 | 780 | 167 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | 1.32e-03 | 401 | 167 | 10 | GSM399450_500 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | 1.32e-03 | 401 | 167 | 10 | GSM791108_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.32e-03 | 333 | 167 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | SEMA4D BRIP1 NACC1 PBK RANBP17 CRYM SAMD9L ALMS1 PRKAA2 ARNT2 LPIN2 PLCB1 KIF14 CRYBG3 LY75 | 1.35e-03 | 783 | 167 | 15 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | NIBAN1 CTTNBP2 ANK3 REV3L CTTNBP2NL DST ARNT2 RSPO2 SLITRK6 CPLANE1 | 1.47e-03 | 407 | 167 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 1.49e-03 | 156 | 167 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2A.Th, Lin-/lo CD25hi CD44+ cKithi, Thymus, avg-2 | 1.53e-03 | 409 | 167 | 10 | GSM791139_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.54e-03 | 275 | 167 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ATRX RBM45 GRK4 ASH1L RNF213 ZNF318 SMC2 KMT2E LARP4 ESCO1 PRRC2C ZNF616 ANKRD12 CPLANE1 TOP1 | 1.57e-03 | 795 | 167 | 15 | gudmap_developingGonad_e16.5_ovary_1000 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SETX SAMD9 ATRX SMCHD1 ASH1L CMPK2 RNF213 KMT2E JUP SAMD9L PRRC2C ANKRD12 DYNC1H1 | 1.50e-12 | 200 | 176 | 13 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | SMCHD1 HSPH1 ASH1L RNF213 TASOR2 ITPR1 NF1 PLCB1 ANKRD36 ANKRD12 DYNC1H1 | 2.54e-10 | 188 | 176 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATRX ASH1L NARS1 APOB LARP4 ADAM10 ESCO1 ZNF518A SAMD9L PRRC2C | 4.94e-09 | 191 | 176 | 10 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATRX ASH1L NARS1 APOB LARP4 ADAM10 ESCO1 ZNF518A SAMD9L PRRC2C | 4.94e-09 | 191 | 176 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATRX ASH1L NARS1 APOB LARP4 ADAM10 ESCO1 ZNF518A SAMD9L PRRC2C | 4.94e-09 | 191 | 176 | 10 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | SETX SAMD9 ATRX SMCHD1 ASH1L RNF213 SAMD9L ZNF638 ANKRD36 ANKRD12 | 6.98e-09 | 198 | 176 | 10 | 4c93ee921d56132d80832d8e94563f32ccf13bbc |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 7.68e-09 | 200 | 176 | 10 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.82e-08 | 186 | 176 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 7.31e-08 | 191 | 176 | 9 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.31e-08 | 191 | 176 | 9 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.35e-08 | 194 | 176 | 9 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.72e-08 | 195 | 176 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.72e-08 | 195 | 176 | 9 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.72e-08 | 195 | 176 | 9 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-08 | 195 | 176 | 9 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.72e-08 | 195 | 176 | 9 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.11e-08 | 196 | 176 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.52e-08 | 197 | 176 | 9 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.52e-08 | 197 | 176 | 9 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 9.52e-08 | 197 | 176 | 9 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 9.94e-08 | 198 | 176 | 9 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.94e-08 | 198 | 176 | 9 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | IL13RA1 CTTNBP2 ANKRD20A2P ANKRD20A3P CTTNBP2NL ANKRD20A4P ASXL3 ARNT2 ANKRD20A1 | 9.94e-08 | 198 | 176 | 9 | da84c76afe835aeee39da04b63c03549218b5d91 |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.94e-08 | 198 | 176 | 9 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.94e-08 | 198 | 176 | 9 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | IL13RA1 CTTNBP2 ANKRD20A2P ANKRD20A3P CTTNBP2NL ANKRD20A4P ASXL3 ARNT2 ANKRD20A1 | 9.94e-08 | 198 | 176 | 9 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.94e-08 | 198 | 176 | 9 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.94e-08 | 198 | 176 | 9 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.04e-07 | 199 | 176 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.04e-07 | 199 | 176 | 9 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.04e-07 | 199 | 176 | 9 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.04e-07 | 199 | 176 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 1.04e-07 | 199 | 176 | 9 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.04e-07 | 199 | 176 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.04e-07 | 199 | 176 | 9 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-07 | 200 | 176 | 9 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-07 | 200 | 176 | 9 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.08e-07 | 200 | 176 | 9 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.08e-07 | 200 | 176 | 9 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.08e-07 | 200 | 176 | 9 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.46e-07 | 149 | 176 | 8 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | IL13RA1 ANKRD20A2P ANKRD20A3P CTTNBP2NL NSUN7 ASXL3 ARNT2 LY75 ANKRD20A1 | 1.51e-07 | 208 | 176 | 9 | 30212cfacad94a7cc562a69efa73a31259851515 |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.82e-07 | 169 | 176 | 8 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-07 | 169 | 176 | 8 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.17e-07 | 171 | 176 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 4.56e-07 | 173 | 176 | 8 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 5.40e-07 | 121 | 176 | 7 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.90e-07 | 179 | 176 | 8 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.16e-07 | 180 | 176 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-07 | 182 | 176 | 8 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-07 | 183 | 176 | 8 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-07 | 183 | 176 | 8 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.58e-07 | 185 | 176 | 8 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-07 | 186 | 176 | 8 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-07 | 187 | 176 | 8 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.55e-07 | 188 | 176 | 8 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.90e-07 | 189 | 176 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.26e-07 | 190 | 176 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.04e-06 | 193 | 176 | 8 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.04e-06 | 193 | 176 | 8 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.08e-06 | 194 | 176 | 8 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 194 | 176 | 8 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 194 | 176 | 8 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-06 | 195 | 176 | 8 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 1.13e-06 | 195 | 176 | 8 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-06 | 196 | 176 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-06 | 196 | 176 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 1.17e-06 | 196 | 176 | 8 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 1.17e-06 | 196 | 176 | 8 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.22e-06 | 197 | 176 | 8 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.22e-06 | 197 | 176 | 8 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-06 | 197 | 176 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 1.22e-06 | 197 | 176 | 8 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 197 | 176 | 8 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 1.22e-06 | 197 | 176 | 8 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.26e-06 | 198 | 176 | 8 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 1.26e-06 | 198 | 176 | 8 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.26e-06 | 198 | 176 | 8 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.31e-06 | 199 | 176 | 8 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.31e-06 | 199 | 176 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 199 | 176 | 8 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | (2)_B_cell-(24)_B_cell_cycling|(2)_B_cell / shred on Cell_type and subtype | 1.31e-06 | 199 | 176 | 8 | d5a9a8a71c4de8cbcef947943f60838731bc640b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 199 | 176 | 8 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-06 | 199 | 176 | 8 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 1.31e-06 | 199 | 176 | 8 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 1.31e-06 | 199 | 176 | 8 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.31e-06 | 199 | 176 | 8 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.31e-06 | 199 | 176 | 8 | 4142d5b1b20212508f95841fdac4efb7655616cb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 199 | 176 | 8 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 1.31e-06 | 199 | 176 | 8 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.31e-06 | 199 | 176 | 8 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-06 | 199 | 176 | 8 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.31e-06 | 199 | 176 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 199 | 176 | 8 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | 1.31e-06 | 199 | 176 | 8 | af78837f3a7641a5bd98765eef9cb4f86034048c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-06 | 199 | 176 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.31e-06 | 199 | 176 | 8 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 1.31e-06 | 199 | 176 | 8 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 1.36e-06 | 200 | 176 | 8 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.36e-06 | 200 | 176 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| Disease | 2-hydroxyglutaric acid measurement | 1.41e-05 | 9 | 165 | 3 | EFO_0010446 | |
| Disease | Insulin Resistance | 2.19e-05 | 60 | 165 | 5 | C0021655 | |
| Disease | Insulin Sensitivity | 2.19e-05 | 60 | 165 | 5 | C0920563 | |
| Disease | Familial monosomy 7 syndrome | 3.11e-05 | 2 | 165 | 2 | cv:C5681220 | |
| Disease | systolic blood pressure, multiple sclerosis | 3.11e-05 | 2 | 165 | 2 | EFO_0006335, MONDO_0005301 | |
| Disease | Malignant neoplasm of breast | RAP1GAP BRIP1 ANK1 OBSCN DGKE ZNF318 ADAM10 LEPR NF1 PRKAA2 NUP133 PLCB1 UTP20 HERC2 CDC27 TOP1 DOP1A | 1.16e-04 | 1074 | 165 | 17 | C0006142 |
| Disease | Meckel syndrome type 1 | 1.32e-04 | 18 | 165 | 3 | C3714506 | |
| Disease | aspartate aminotransferase measurement | BRIP1 THSD7A GAS6 OBSCN RNF213 LEPR ITPR1 NPHP3 NF1 ZNF638 LY75 GCN1 ALPK2 MTARC1 MYBPC3 | 1.79e-04 | 904 | 165 | 15 | EFO_0004736 |
| Disease | Malignant Peripheral Nerve Sheath Tumor | 1.85e-04 | 4 | 165 | 2 | C0751690 | |
| Disease | mean platelet volume | NIBAN1 EDC3 GRK4 U2SURP NACA LRRK2 ITGA2B STIL LRRC8D LEPR PVR PLCB1 GNAS LY75 GGNBP1 MYBPC3 | 2.05e-04 | 1020 | 165 | 16 | EFO_0004584 |
| Disease | obesity (implicated_via_orthology) | 2.17e-04 | 215 | 165 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.45e-04 | 22 | 165 | 3 | C3711387 | |
| Disease | neuroblastoma (implicated_via_orthology) | 3.07e-04 | 5 | 165 | 2 | DOID:769 (implicated_via_orthology) | |
| Disease | free cholesterol measurement | 4.44e-04 | 113 | 165 | 5 | EFO_0008591 | |
| Disease | nephronophthisis (is_implicated_in) | 4.59e-04 | 6 | 165 | 2 | DOID:12712 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 4.62e-04 | 114 | 165 | 5 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 4.62e-04 | 114 | 165 | 5 | EFO_0004574, EFO_0004611 | |
| Disease | Polydactyly | 5.21e-04 | 117 | 165 | 5 | C0152427 | |
| Disease | MYELODYSPLASTIC SYNDROME | 5.49e-04 | 67 | 165 | 4 | C3463824 | |
| Disease | Hematopoetic Myelodysplasia | 5.64e-04 | 29 | 165 | 3 | C2713368 | |
| Disease | esterified cholesterol measurement | 7.83e-04 | 128 | 165 | 5 | EFO_0008589 | |
| Disease | Microlissencephaly | 8.28e-04 | 33 | 165 | 3 | C1956147 | |
| Disease | choline measurement | 8.39e-04 | 130 | 165 | 5 | EFO_0010116 | |
| Disease | Autistic behavior | 8.51e-04 | 8 | 165 | 2 | C0856975 | |
| Disease | Nephronophthisis | 1.09e-03 | 9 | 165 | 2 | cv:C0687120 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 1.09e-03 | 9 | 165 | 2 | C4225275 | |
| Disease | phospholipid measurement | 1.17e-03 | 140 | 165 | 5 | EFO_0004639 | |
| Disease | Sclerocystic Ovaries | 1.32e-03 | 144 | 165 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.32e-03 | 144 | 165 | 5 | C0032460 | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.34e-03 | 85 | 165 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | Meckel-Gruber syndrome | 1.36e-03 | 10 | 165 | 2 | cv:C0265215 | |
| Disease | aortic aneurysm | 1.36e-03 | 10 | 165 | 2 | EFO_0001666 | |
| Disease | migraine disorder, Headache | 1.40e-03 | 86 | 165 | 4 | HP_0002315, MONDO_0005277 | |
| Disease | Kidney Diseases | 1.53e-03 | 88 | 165 | 4 | C0022658 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 1.65e-03 | 11 | 165 | 2 | OBA_2045170 | |
| Disease | lipid measurement, lipoprotein measurement | 1.66e-03 | 90 | 165 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | household income | 1.67e-03 | 304 | 165 | 7 | EFO_0009695 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.72e-03 | 225 | 165 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | Neurodevelopmental Disorders | 1.87e-03 | 93 | 165 | 4 | C1535926 | |
| Disease | Bardet-Biedl Syndrome | 2.33e-03 | 13 | 165 | 2 | C0752166 | |
| Disease | Adenoid Cystic Carcinoma | 2.44e-03 | 100 | 165 | 4 | C0010606 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.53e-03 | 101 | 165 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | platelet crit | TRIB2 ATRX U2SURP LRRK2 APOB ZNF318 ITGA2B LEPR NUP205 NF1 PLCB1 LY75 GGNBP1 | 2.78e-03 | 952 | 165 | 13 | EFO_0007985 |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.94e-03 | 51 | 165 | 3 | EFO_0022285 | |
| Disease | pancreatic carcinoma | 3.02e-03 | 174 | 165 | 5 | EFO_0002618 | |
| Disease | quinate measurement | 3.11e-03 | 15 | 165 | 2 | EFO_0021167 | |
| Disease | Autosomal recessive primary microcephaly | 3.11e-03 | 15 | 165 | 2 | cv:C3711387 | |
| Disease | N-acetylmethionine measurement | 3.11e-03 | 15 | 165 | 2 | EFO_0021427 | |
| Disease | C-reactive protein measurement | SEMA4D MMS22L RAP1GAP ANK3 APOB IL22RA1 LEPR ITPR1 RANBP17 PVR SLITRK6 GCN1 TOP1 GGNBP1 MYBPC3 | 3.26e-03 | 1206 | 165 | 15 | EFO_0004458 |
| Disease | fatty acid measurement | 3.27e-03 | 436 | 165 | 8 | EFO_0005110 | |
| Disease | Alzheimer's disease (is_marker_for) | 3.33e-03 | 257 | 165 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Ciliopathies | 3.44e-03 | 110 | 165 | 4 | C4277690 | |
| Disease | Acute Cerebrovascular Accidents | 3.46e-03 | 54 | 165 | 3 | C0751956 | |
| Disease | asthma, response to diisocyanate | 3.59e-03 | 261 | 165 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | leukemia | 3.64e-03 | 55 | 165 | 3 | C0023418 | |
| Disease | clonal hematopoiesis mutation measurement | 3.64e-03 | 55 | 165 | 3 | EFO_0020949 | |
| Disease | Intellectual Disability | 3.79e-03 | 447 | 165 | 8 | C3714756 | |
| Disease | cholesterol to total lipids in large LDL percentage | 3.83e-03 | 56 | 165 | 3 | EFO_0022235 | |
| Disease | renal fibrosis (implicated_via_orthology) | 4.00e-03 | 17 | 165 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Lipidemias | 4.00e-03 | 17 | 165 | 2 | C1706412 | |
| Disease | Moyamoya Disease | 4.00e-03 | 17 | 165 | 2 | C0026654 | |
| Disease | Hyperlipidemia | 4.00e-03 | 17 | 165 | 2 | C0020473 | |
| Disease | blood urea nitrogen measurement | 4.05e-03 | 452 | 165 | 8 | EFO_0004741 | |
| Disease | triglycerides in IDL measurement | 4.23e-03 | 58 | 165 | 3 | EFO_0022149 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 4.53e-03 | 364 | 165 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.65e-03 | 60 | 165 | 3 | EFO_0022233 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 4.68e-03 | 120 | 165 | 4 | EFO_0004611, EFO_0004639 | |
| Disease | alkaline phosphatase measurement | RAP1GAP SAMD9 U2SURP GAS6 APOB ZNF318 LEPR ITPR1 NPHP3 NF1 ALPK2 MTARC1 MYBPC3 | 4.76e-03 | 1015 | 165 | 13 | EFO_0004533 |
| Disease | Cerebrovascular accident | 5.10e-03 | 62 | 165 | 3 | C0038454 | |
| Disease | mean reticulocyte volume | RAP1GAP BRIP1 SAMD9 ANK1 GAS6 ZNF318 NUP205 TPX2 LPIN2 ZNF638 LY75 | 5.47e-03 | 799 | 165 | 11 | EFO_0010701 |
| Disease | myelodysplastic syndrome (is_marker_for) | 5.53e-03 | 20 | 165 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | Familial aplasia of the vermis | 5.53e-03 | 20 | 165 | 2 | cv:C0431399 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 5.56e-03 | 126 | 165 | 4 | EFO_0004611, EFO_0010351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATKQCVPEKVSEPLP | 296 | Q5TYW2 | |
| QKKLCPLSLTSLPRE | 96 | P84996 | |
| EKQPVCTNPLSILKV | 71 | Q9P2B4 | |
| SVDSKPPVISLQKLI | 726 | Q6ZSZ5 | |
| VTEKLAQLIATCPPS | 216 | Q9NR48 | |
| KLEELQTLCKTPPRS | 1231 | O94986 | |
| ATKQCVPEKVSEPLP | 296 | Q5CZ79 | |
| KPCVSPTVGEKNLLV | 1276 | Q68DQ2 | |
| VALSVTQDPACKKPL | 271 | P46952 | |
| QARPVGVKIPTCKIT | 196 | O95433 | |
| IKSTKELLCRAPSVP | 1066 | Q86TB3 | |
| IKICSVHTPSSNPKL | 696 | O14672 | |
| SVAIKLCNLLKIAPP | 116 | P17405 | |
| ATKQCVPEKVSEPLP | 296 | Q4UJ75 | |
| RCPLDALNTTKPKSL | 381 | P54646 | |
| SSCIPLLRLPDKQQK | 51 | Q8N888 | |
| PTRITCRLVKPQKLS | 946 | P16157 | |
| QVTKKAPLCLDTDQP | 111 | Q86SQ6 | |
| KEKNVTITPDLPSCI | 2866 | Q8TCU4 | |
| CSKILSKVQPPLLSA | 536 | Q5JWR5 | |
| KTLNSTLKCELPVQL | 361 | Q4L235 | |
| ECPDLKTKLLVSPQS | 181 | P0C7M7 | |
| RTVSSPKQPALKAIC | 1121 | A6QL64 | |
| VSLTDKIQLACLPPA | 131 | P08217 | |
| ICESKQILPSKTPLP | 341 | Q6UB98 | |
| QPTVKPDLVGKLSRC | 426 | Q9Y2E6 | |
| EIPNTALVKFCKPLI | 361 | Q8TAM1 | |
| SLSKKCLLLSPPVAE | 331 | Q96LY2 | |
| RYTTEIIKCPQPKTL | 301 | P00736 | |
| IIKCPQPKTLDEFTI | 306 | P00736 | |
| SPEVKQQKRLLPSCS | 1891 | Q9C0F0 | |
| PTCSALARKPDKLTI | 91 | Q9HBZ2 | |
| IATKFLKPPSSEVLC | 126 | Q14894 | |
| CDIKPQIKTSDPSTL | 106 | Q8TD07 | |
| CLSKLVSRVSPLPVE | 66 | Q9H2T7 | |
| IQTDVVLPSCKKKAP | 371 | Q8IUH3 | |
| EIKKTVPPCVSRSLE | 1046 | Q6P2E9 | |
| CSIPPVLKAELLKTL | 636 | Q92621 | |
| IIPLLKISCTDPSIN | 181 | P0DN80 | |
| ATKQCVPEKVSEPLP | 296 | Q5SQ80 | |
| VPLVSKICPSDTYKV | 141 | Q86YJ7 | |
| SPITKLSVCKELQLP | 131 | Q8WUM0 | |
| KVPLLEKCLQNSITP | 351 | M0R2J8 | |
| KLTTKCSLPQLKSPA | 286 | Q15058 | |
| VPALLKLSCADTKPI | 181 | O76000 | |
| LPKCTEIKPEVNTLT | 286 | A0AUZ9 | |
| TNSCIPEIITTKDPI | 136 | Q9Y5Y7 | |
| LPIKTPTTNAVHKCR | 136 | Q5VT66 | |
| IKNKTTCVPVQLHPS | 96 | Q8NA97 | |
| CIIPGPISKNIKQSL | 1086 | Q68CZ1 | |
| PNLPPVTKSLVTNCK | 1081 | Q3T906 | |
| RILKPCSTPSDKLVI | 591 | Q8NI17 | |
| PVTQELICKAVLNPT | 646 | Q14643 | |
| CSNSTQKVPIPVLLV | 246 | P59045 | |
| PSPISVAQCLLLEEK | 86 | Q5YKI7 | |
| AKVKVPTPCEALATL | 3971 | O95714 | |
| TKALIQPSKCSPLVN | 216 | Q9NS40 | |
| TATIPPISSLKKCIV | 1056 | Q6ZRQ5 | |
| AKTIIQLKPRNSDCP | 871 | Q03001 | |
| NSDCPLKTSIPIKAI | 881 | Q03001 | |
| LVAAAIDAPKTCSPK | 16 | Q07954 | |
| AGKTIIPLISQCTPK | 201 | P40926 | |
| PAKLNLLTCQVKTNP | 346 | O43150 | |
| VSPKCLTSALQIPVT | 1731 | Q5HYC2 | |
| NSLKKPVTDCVISVP | 131 | Q92598 | |
| CTTVLPQIEKLLQSK | 556 | Q9BVA0 | |
| EPSLSPKLTCLQNLK | 136 | P08174 | |
| TVKVPTPLCTARQLD | 336 | Q14654 | |
| SSPLQVAIKTLPELC | 536 | P29376 | |
| AKSKCTNPRITEIIP | 851 | Q9HCM2 | |
| IITETEVPALNKCPT | 711 | Q8IZD2 | |
| LDPTVKCPTLKQFNL | 1076 | Q5S007 | |
| VKPVDSVKCPSPVLN | 1231 | O60449 | |
| AKSKSVSLPVPDLCA | 591 | P48357 | |
| ILLAEKTCPSTPEKT | 241 | A0A087WXM9 | |
| QLSSCLPNIVPKLTE | 1531 | Q92616 | |
| CRKVPILTELKNPSN | 856 | A8MYU2 | |
| LKDLPTSPVDLVINC | 396 | Q96F86 | |
| LQVITLLTCTSPKKV | 316 | Q5TGP6 | |
| KVLSVCPSNKPAIVE | 336 | P14923 | |
| CPVVVLPDTLKITNS | 266 | Q6UXL0 | |
| ESEKPSILVEKCISP | 106 | P78552 | |
| PCSIKVLDKATVPII | 306 | Q5XG87 | |
| LQCPKIITKNSPLPS | 946 | Q9BX63 | |
| VKLACRVTGTPKPVI | 6031 | Q5VST9 | |
| PLISSSPKLSECLQK | 506 | O00471 | |
| ATKQCVPEKVSEPLP | 296 | Q5VUR7 | |
| QLTPELKSSILKCVQ | 501 | P04114 | |
| LKAVLLKSPPSCIGQ | 276 | Q5EBM0 | |
| ASPTKCPITTKLVLD | 1526 | P46100 | |
| TACSPEESCVLKKPI | 621 | Q659A1 | |
| TIQVACLPEKDSLLP | 136 | Q99895 | |
| PSLKDKPKVIIIQAC | 271 | P29466 | |
| VSLTDKIQLACLPPA | 131 | P08218 | |
| LSPENRCKKTQLIPL | 2406 | Q9H799 | |
| ISSACLIPVKQSPSK | 1176 | Q8WZ74 | |
| LPCVPFSVAKSVKSL | 281 | Q14393 | |
| PVICSKLLLTKRVSP | 31 | Q8IZF7 | |
| LPSKLPVKVRSTCVT | 3946 | Q12955 | |
| SKLIIEETKPCVPVS | 4311 | Q12955 | |
| KSQTILKPLSECKSP | 406 | Q99741 | |
| TREVCPLTVKPKETI | 221 | Q8IY82 | |
| EVCQKPPKEPSSVLV | 621 | Q71RC2 | |
| LKPPDVTCISKVRSI | 121 | Q8N6P7 | |
| PITCELLNKQVKVSP | 1996 | Q14204 | |
| SLPKCNSHLEITIPK | 576 | Q5FWF5 | |
| LQLKDPTCRPKLSNV | 301 | Q86UP6 | |
| DVTKTPPIKALQLCT | 251 | P52429 | |
| PEKISSTLKVEPCSL | 206 | Q96EB1 | |
| PCQKPSTSKVILRAV | 111 | P60008 | |
| KEILTLPPVSQCSEL | 31 | P32298 | |
| PPASTCKVLVESKLR | 366 | A6NKF1 | |
| RVCVVSVEKPTLPSK | 411 | O00411 | |
| TLNKAIVIDPKNPLC | 691 | P30260 | |
| LPLVAVCQVTSTPDK | 46 | Q86X76 | |
| LKCPKPSAQEITNLA | 426 | P20264 | |
| KILVPEKSLPCKVSN | 516 | P54277 | |
| QLTKDQVVCLPVLPS | 46 | Q7L1W4 | |
| LVPIPSCETPKLATK | 791 | Q96DY7 | |
| PVDKPINTTLICNVT | 301 | P15151 | |
| IKRVKDGPPSLTTIC | 246 | O75529 | |
| TKIPTPADVCKVLSQ | 336 | O75691 | |
| KQLPLTSICLETDSP | 206 | Q17R31 | |
| PSCKDVAPVEKTIKL | 1016 | A6NHR9 | |
| SILSRLKKESICPTP | 256 | Q9H5Y7 | |
| QCQPVISKSLEKPLE | 131 | Q9UPZ6 | |
| ITIKNDPSLPEPKCV | 101 | O43776 | |
| PLSPKDAKSIIIAEC | 671 | Q7Z494 | |
| CVPSLKKVQLPSLSK | 566 | Q9H3E2 | |
| SCLKPNSKLIQPLTT | 1391 | Q8IVG5 | |
| SCIQPTSRLVKPVEK | 1396 | Q5K651 | |
| KIKPCLTIDSSPLSA | 411 | Q587J7 | |
| PVLPLCSLKEIQLST | 471 | Q8NE18 | |
| APILPVKKISRSCSV | 221 | Q5T036 | |
| LKRELPSSSPVCIQV | 191 | Q7Z3Z4 | |
| IPKVTSRCIDSKEPI | 946 | Q9Y520 | |
| PLQSPTTKVKLECNP | 71 | P47736 | |
| LCTCTEPIRKVPVSK | 1226 | Q7Z333 | |
| PILKIPCSDTSLIEQ | 181 | A6NDL8 | |
| IPKTKRPEIDCTLVA | 106 | Q8TE99 | |
| TSCEPKIVINTVPQL | 706 | Q92854 | |
| SLNPAVKSCVLPQTK | 496 | P08514 | |
| VKSCVLPQTKTPVSC | 501 | P08514 | |
| KASNPKILSLCPEIK | 76 | O94903 | |
| KVCTLPLPVCKTVAI | 356 | Q5PT55 | |
| IVKKPVKDTILCPTI | 176 | Q6UXX9 | |
| CITESLSILKTPLPK | 576 | O15042 | |
| KPLERQPSNAILKTC | 151 | P32247 | |
| PVDCPVRSKLKTGLI | 611 | Q63HN8 | |
| KISKIQPSVPELSLV | 416 | Q15468 | |
| KCVIKELPPTENSNT | 51 | Q08AN1 | |
| ILNVSVLVKPSKPLC | 131 | Q86XK7 | |
| VLVKPSKPLCSVQGR | 136 | Q86XK7 | |
| PTVQKALASTCKPEL | 506 | Q9BZQ8 | |
| DTCQSPLTQAPVKKV | 21 | O60673 | |
| KTLLLCSPQPDGKVV | 286 | Q9BSV6 | |
| APIAKKEISLPILCN | 371 | Q5TCZ1 | |
| SCFLVEKQPPQVLKT | 271 | P42226 | |
| FNIPETLSPKAKCLI | 271 | Q92519 | |
| SDSNPLTEILKCPTK | 291 | Q96I25 | |
| KIIDKTCLSPTPTLE | 2056 | P21359 | |
| KKKSVLCSTPTINIP | 16 | Q96KB5 | |
| RGTVTKEPCKTPILK | 1001 | Q6AHZ1 | |
| VNKEIIRSKPPICTL | 341 | Q8TEA7 | |
| SQDPPEKSIPICTLK | 621 | P22314 | |
| PIVFKKVVLPTLACL | 731 | Q9NQ66 | |
| VSCSTIPPELVKQKV | 491 | Q9BVS4 | |
| IPLNKISARCIAPET | 576 | O95347 | |
| IVCLNKVTKSFPPLA | 2361 | P78527 | |
| QKKPASCVLVSPSNL | 1241 | Q96JM2 | |
| LCLQKAPASKTLTLP | 256 | P0C7H9 | |
| KAVCSLQKETPLPVS | 1136 | Q5VWN6 | |
| CSSLKLTKIPERIPQ | 526 | O75093 | |
| EPSLSTQTLPVIKCS | 1161 | Q14679 | |
| DIIINCSKDAKVPSP | 381 | P11387 | |
| ETPSKVVIKLSPQAC | 1846 | Q5VUA4 | |
| TCSLSPKIDLPEVQI | 1076 | Q14966 | |
| SKPQNPITRLCSLKE | 151 | Q96M85 | |
| TKICRDPQTPVLQTK | 361 | Q9ULW0 | |
| VCTIVKPKPRALGTQ | 321 | Q92539 | |
| QLLKASSKKCIPDPI | 281 | Q93070 | |
| SSKKCIPDPIAIASL | 286 | Q93070 | |
| LTTKKDPTVLPLVQA | 551 | E9PAV3 | |
| CSTPLPLVSRVKTEQ | 156 | Q96RE7 | |
| SKQGVLTLEIRKPCP | 1231 | Q14896 |